NEW YORK (GenomeWeb News) – BGS Acquisition today announced it is purchasing genotyping firm TransnetYX Holding Corp. in a cash and stock deal.

BGS is buying TransnetYX as part of an amended and restated merger agreement with diversified holding company Black Diamond Holdings. The two firms had announced in June an agreement to complete a business combination. The deal included TransnetYX, in which Black Diamond has a majority stake.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.